MF
Mani Foroohar Leerink Partners Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
26
Moderna
MRNA
$9.52B
| $24.47 | $93 |
280%
upside
| Underperform |
24 Feb ‘23
2 years ago |
|
27
Ionis Pharmaceuticals
IONS
$10.3B
| $64.40 | $27 |
58%
downside
| Market Perform |
23 Feb ‘23
2 years ago |
|
28
4D Molecular Therapeutics
FDMT
$326M
| $6.97 | $14 |
101%
upside
| Market Perform |
6 Feb ‘23
2 years ago |
|
29
Recursion Pharmaceuticals
RXRX
$2.05B
| $4.70 | $8 |
70%
upside
| Market Perform |
23 Jan ‘23
2 years ago |
|
30
Regenxbio
RGNX
$500M
| $9.89 | $14 |
42%
upside
| Market Perform |
23 Jan ‘23
2 years ago |
|
31
Rocket Pharmaceuticals
RCKT
$346M
| $3.21 | $49 |
1,426%
upside
| Outperform |
23 Jan ‘23
2 years ago |
|
32
Intellia Therapeutics
NTLA
$1.28B
| $11.88 | $84 |
607%
upside
| Outperform |
23 Jan ‘23
2 years ago |
|
33
Editas Medicine
EDIT
$248M
| $2.76 | $7 |
154%
upside
| Market Perform |
23 Jan ‘23
2 years ago |
|
34
Beam Therapeutics
BEAM
$2.06B
| $20.36 | $77 |
278%
upside
| Outperform |
23 Jan ‘23
2 years ago |
|
35
BridgeBio Pharma
BBIO
$10.2B
| $53.50 | $19 |
64%
downside
| Outperform |
23 Jan ‘23
2 years ago |
|
|
KLRS
36
Kalaris Therapeutics, Inc. Common Stock
KLRS
$87.5M
| $4.68 | $437 |
9,238%
upside
| Outperform |
23 Jan ‘23
2 years ago |
|
37
Alnylam Pharmaceuticals
ALNY
$63.2B
| $482.13 | $143 |
70%
downside
| Market Perform |
23 Jan ‘23
2 years ago |
|
38
Mirum Pharmaceuticals
MIRM
$3.9B
| $77.69 | $39 |
50%
downside
| Outperform |
10 Jan ‘23
2 years ago |
|
|
LENZ
39
LENZ Therapeutics
LENZ
$1.14B
| $39.89 | $14 |
65%
downside
| Market Perform |
6 Jan ‘23
2 years ago |
|
40
Wave Life Sciences
WVE
$1.19B
| $7.48 | $7 |
6%
downside
| Market Perform |
14 Dec ‘22
2 years ago |
|
41
Abeona Therapeutics
ABEO
$350M
| $6.83 | $6 |
12%
downside
| Market Perform |
14 Nov ‘22
2 years ago |
|
42
CRISPR Therapeutics
CRSP
$4.88B
| $53.69 | $76 |
42%
upside
| Outperform |
7 Nov ‘22
2 years ago |
|
43
Tourmaline Bio
TRML
$1.22B
| $47.64 | $20 |
58%
downside
| Market Perform |
20 Oct ‘22
2 years ago |
|
44
Caribou Biosciences
CRBU
$171M
| $1.84 | $34 |
1,748%
upside
| Outperform |
12 May ‘22
3 years ago |
|
45
Adverum Biotechnologies
ADVM
$72.8M
| $3.47 | $20 |
476%
upside
| Market Perform |
23 Jul ‘21
4 years ago |
|
|
TECX
46
Tectonic Therapeutic, Inc. Common Stock
TECX
$322M
| $17.22 | $120 |
597%
upside
| Market Perform |
3 May ‘21
4 years ago |
|